Pharmacosmos sponsor at ESPHM 2019

April 4, 2019

Pharmacosmos has signed up as sponsor at the 11th European Symposium of Porcine Health Management. in Utrecht/Netherlands - from the 22nd - 22th of May 2019.

We welcome new and existing Uniferon customers to visit our exhibition where we would be pleased to inform you about Uniferon and discuss optimized anaemia care.

Visit us at our Exhibition stand 26, floor 7, Pandora.

For additional information about ESPHM 2019, please visit:

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.